EA201290097A1 - Спиртовые композиции, имеющие пониженный риск возникновения ацетальдегидемии - Google Patents

Спиртовые композиции, имеющие пониженный риск возникновения ацетальдегидемии

Info

Publication number
EA201290097A1
EA201290097A1 EA201290097A EA201290097A EA201290097A1 EA 201290097 A1 EA201290097 A1 EA 201290097A1 EA 201290097 A EA201290097 A EA 201290097A EA 201290097 A EA201290097 A EA 201290097A EA 201290097 A1 EA201290097 A1 EA 201290097A1
Authority
EA
Eurasian Patent Office
Prior art keywords
acetaldehydhemia
occurrence
reduced risk
alcoholic compositions
compositions
Prior art date
Application number
EA201290097A
Other languages
English (en)
Other versions
EA023867B1 (ru
Inventor
Энтони Кзарник
Джеффри Маккинни
Original Assignee
ПРОШИА ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ПРОШИА ЭлЭлСи filed Critical ПРОШИА ЭлЭлСи
Publication of EA201290097A1 publication Critical patent/EA201290097A1/ru
Publication of EA023867B1 publication Critical patent/EA023867B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C12/00—Processes specially adapted for making special kinds of beer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

В изобретении предложены напитки и фармацевтические композиции, содержащие дейтерированный спирт согласно формуле 1, и предложены способы их изготовления и применения. Ожидается, что композиции по изобретению ослабляют некоторые негативные побочные эффекты, связанные с потреблением спирта, такие как похмелье и покраснение лица.
EA201290097A 2009-08-21 2010-08-20 Спиртовые композиции, имеющие пониженный риск возникновения ацетальдегидемии EA023867B1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US27487509P 2009-08-21 2009-08-21
US28086009P 2009-11-09 2009-11-09
US28352409P 2009-12-04 2009-12-04
US12/777,238 US8658236B2 (en) 2009-08-21 2010-05-10 Alcoholic compositions having a lowered risk of acetaldehydemia
PCT/US2010/046211 WO2011022682A1 (en) 2009-08-21 2010-08-20 Alcoholic compositions having a lowered risk of acetaldehydemia

Publications (2)

Publication Number Publication Date
EA201290097A1 true EA201290097A1 (ru) 2012-08-30
EA023867B1 EA023867B1 (ru) 2016-07-29

Family

ID=43605849

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290097A EA023867B1 (ru) 2009-08-21 2010-08-20 Спиртовые композиции, имеющие пониженный риск возникновения ацетальдегидемии

Country Status (32)

Country Link
US (6) US8658236B2 (ru)
EP (1) EP2467465B1 (ru)
JP (1) JP5862965B2 (ru)
KR (1) KR101462740B1 (ru)
CN (2) CN103300449B (ru)
AP (1) AP3676A (ru)
AU (1) AU2010284051B2 (ru)
BR (1) BR112012003560A8 (ru)
CA (1) CA2771166C (ru)
CL (1) CL2012000448A1 (ru)
CO (1) CO6511227A2 (ru)
CY (1) CY1119041T1 (ru)
DK (1) DK2467465T3 (ru)
EA (1) EA023867B1 (ru)
ES (1) ES2635730T3 (ru)
GE (1) GEP20146057B (ru)
HK (1) HK1171245A1 (ru)
HR (1) HRP20171225T1 (ru)
HU (1) HUE036124T2 (ru)
IL (1) IL218201A (ru)
LT (1) LT2467465T (ru)
ME (1) ME02866B (ru)
MX (1) MX2012002089A (ru)
MY (1) MY156177A (ru)
NZ (1) NZ598452A (ru)
PL (1) PL2467465T3 (ru)
PT (1) PT2467465T (ru)
RS (1) RS56120B1 (ru)
SG (1) SG178521A1 (ru)
SI (1) SI2467465T1 (ru)
WO (1) WO2011022682A1 (ru)
ZA (1) ZA201202075B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2719145T3 (es) 2011-06-20 2019-07-08 H Lundbeck As 1-Piperazino-3-fenil-indanos deuterados para el tratamiento de la esquizofrenia
US9803163B2 (en) 2012-04-05 2017-10-31 Anheuser-Busch Llc Systems for carbonating customized beverages
BR112015005894B1 (pt) 2012-09-18 2022-03-29 Auspex Pharmaceuticals, Inc Composto, composição farmacêutica, método para tratar um distúrbio mediado por vmat2 e formulação farmacêutica de liberação prolongada
JP6670232B2 (ja) 2013-03-15 2020-03-18 デューテリア アグロケミカルズ, リミテッド ライアビリティー カンパニーDeuteria Agrochemicals, LLC 重水素富化アルデヒド
US9713330B1 (en) 2013-03-15 2017-07-25 Deuteria Agrochemicals, Llc Deuterium-enriched aldehydes
PT3194557T (pt) 2014-09-16 2020-09-21 Roar Holding Llc Bebidas energéticas e outras ajudas nutricionais derivadas de bebidas espirituosas à base de agave
CN114403335A (zh) * 2014-12-09 2022-04-29 以西结·戈兰 酒精饮料替代品
KR102528845B1 (ko) 2015-03-06 2023-05-08 오스펙스 파마슈티칼스, 인코포레이티드 비정상적 불수의 운동 장애의 치료 방법
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US10289381B2 (en) * 2015-12-07 2019-05-14 Motorola Mobility Llc Methods and systems for controlling an electronic device in response to detected social cues
CN110545912B (zh) 2017-04-27 2022-10-04 杜特里亚饮料有限责任公司 用于由d2o制备氘代乙醇的方法
CN110545911B (zh) 2017-04-27 2022-12-27 杜特里亚饮料有限责任公司 用于由d2制备氘代乙醇的方法
CN109330632B (zh) * 2018-11-09 2023-09-29 上海导向医疗***有限公司 活检旋切装置
US11535600B2 (en) 2018-12-03 2022-12-27 H. Lundbeck A/S Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazine
US10582716B1 (en) 2019-06-14 2020-03-10 Lennham Pharmaceuticals, Inc. Deuterated caffeine and uses thereof
USD963194S1 (en) 2020-12-09 2022-09-06 TMRW Life Sciences, Inc. Cryogenic vial carrier

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156408A (en) * 1974-11-08 1976-05-18 Piasu Chem Co Karubonsanno jusuisokaesuteruno seizohoho
DE3413085A1 (de) 1984-04-06 1985-10-24 Henkell & Co, 6200 Wiesbaden Verfahren zum herabsetzen des alkoholgehalts alkoholhaltiger getraenke, insbesondere wein und schaumwein
US4612196A (en) 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5223269A (en) 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
JPH05156408A (ja) * 1991-11-29 1993-06-22 Nippon Steel Corp 溶接性に優れた高強度マルテンサイトステンレス鋼とその製造方法
DE4343838C2 (de) 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
WO1995018545A1 (en) * 1994-01-06 1995-07-13 Hyd Kutató-Fejlesztó Ktf. Food products for preventing development of diseases and process for preparing same
CN1143308A (zh) * 1994-01-06 1997-02-19 Hyd探索发展有限公司 预防疾病发生的食品及其制备方法
WO1995026325A2 (en) 1994-03-25 1995-10-05 Isotechnika Inc. Enhancement of the efficacy of drugs by deuteration
GB2293100A (en) 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
KR100387229B1 (ko) 1995-11-01 2003-08-21 삼성전자주식회사 영상부호화장치
US6376531B1 (en) 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
DE10362026B4 (de) 2003-12-19 2009-01-08 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verwendung von Palatinose zur Verbesserung der Lagerungsstabilität eines bierähnlichen Erfrischungsgetränkes
PT1846546E (pt) * 2005-02-08 2011-07-06 Woodford Associates Ltd Bebida alcoólica enriquecida com 1h2 16o
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
US7713773B2 (en) * 2005-11-02 2010-05-11 Solopower, Inc. Contact layers for thin film solar cells employing group IBIIIAVIA compound absorbers
US20080301122A1 (en) * 2007-05-31 2008-12-04 Amadeus S.A.S. Searching techniques
US20090046823A1 (en) * 2007-08-14 2009-02-19 Texas Instruments Incorporated Neutron generating device
JP5156408B2 (ja) * 2008-01-24 2013-03-06 京セラドキュメントソリューションズ株式会社 濃度測定装置および画像形成装置

Also Published As

Publication number Publication date
EP2467465A1 (en) 2012-06-27
CA2771166A1 (en) 2011-02-24
BR112012003560A2 (pt) 2020-10-27
US10047330B2 (en) 2018-08-14
JP2013502227A (ja) 2013-01-24
ZA201202075B (en) 2013-08-28
CN102471742B (zh) 2013-05-29
US20190062680A1 (en) 2019-02-28
KR20120053510A (ko) 2012-05-25
DK2467465T3 (en) 2017-09-11
ME02866B (me) 2018-04-20
BR112012003560A8 (pt) 2020-12-01
CN103300449B (zh) 2015-05-06
HRP20171225T1 (hr) 2017-10-20
GEP20146057B (en) 2014-03-10
CN102471742A (zh) 2012-05-23
MX2012002089A (es) 2012-07-03
AU2010284051B2 (en) 2014-12-04
SI2467465T1 (sl) 2017-09-29
ES2635730T3 (es) 2017-10-04
KR101462740B1 (ko) 2014-11-17
CL2012000448A1 (es) 2012-08-31
CA2771166C (en) 2015-02-24
RS56120B1 (sr) 2017-10-31
EP2467465A4 (en) 2013-09-25
PT2467465T (pt) 2017-09-11
US8658236B2 (en) 2014-02-25
AU2010284051A1 (en) 2012-03-08
JP5862965B2 (ja) 2016-02-16
WO2011022682A1 (en) 2011-02-24
US10731116B2 (en) 2020-08-04
US9732311B2 (en) 2017-08-15
EA023867B1 (ru) 2016-07-29
PL2467465T3 (pl) 2017-11-30
IL218201A0 (en) 2012-04-30
EP2467465B1 (en) 2017-06-07
NZ598452A (en) 2012-12-21
AP3676A (en) 2016-04-16
US20210038511A1 (en) 2021-02-11
US20180030394A1 (en) 2018-02-01
US9044423B2 (en) 2015-06-02
LT2467465T (lt) 2017-11-27
CY1119041T1 (el) 2018-01-10
US20160137959A1 (en) 2016-05-19
US20150011651A1 (en) 2015-01-08
SG178521A1 (en) 2012-04-27
HUE036124T2 (hu) 2018-06-28
US11298317B2 (en) 2022-04-12
US20110046236A1 (en) 2011-02-24
CO6511227A2 (es) 2012-08-31
IL218201A (en) 2015-09-24
MY156177A (en) 2016-01-15
CN103300449A (zh) 2013-09-18
AP2012006133A0 (en) 2012-02-29
HK1171245A1 (en) 2013-03-22

Similar Documents

Publication Publication Date Title
EA201290097A1 (ru) Спиртовые композиции, имеющие пониженный риск возникновения ацетальдегидемии
EA201490493A1 (ru) Пирано[3,2-d][1,3]тиазол в качестве ингибиторов гликозидазы
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
BRPI0907727A2 (pt) composições farmacêuticas de entacapone co-micronizado com alcoóis de açúcar
UA108205C2 (uk) Алкогольна композиція, що містить дейтерований спирт і має знижений ризик ацетальдегідемії
TH91753B (th) แก้ว
TH90334B (th) ขวด
TH122163B (th) "องค์ประกอบแอลกอฮอล์ที่มีความต่ำต่ออะเซตาลดีไฮดีเมีย"
RU2011127039A (ru) Алкогольный напиток
TH91521B (th) ขวด
TH126759B (th) แว่นตา
TH114335B (th) ขวด
TH102354B (th) โคมไฟ
TH132492B (th) รถยนต์
TH117106B (th) รถยนต์
EA201490757A1 (ru) 5,5-диметил-2-пропил-гексагидро-2,4а-метанонафталин-1-он в качестве ароматизирующего вещества
TH100237B (th) เก้าอี้
TH100239B (th) เก้าอี้
TH100240B (th) เก้าอี้
TH100234B (th) เก้าอี้
TH100235B (th) เก้าอี้
TH100236B (th) เก้าอี้
UA91166C2 (en) use of ethyl ether N-[(2-oxoindolylinylydene-3)-2-oxyacetyl]-aminoacetic acid of the general formula as nootropic and anxyolytic agent

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment